One-Year Study of S1B-509 vs Placebo for Weight Loss

Status:
NOT_YET_RECRUITING

Trial end date:
2027-12-15

Target enrollment:

Participant gender:

This is a study to test whether S1B-509 given orally daily helps people with overweight or obesity to lose more weight than with placebo over a year.

PHASE2

S1 Biopharma, Inc.